Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Rating of “Hold” from Analysts

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have received a consensus rating of “Hold” from the twelve research firms that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $5.35.

A number of equities research analysts have recently issued reports on the stock. The Goldman Sachs Group cut their price target on shares of Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Finally, Barclays lowered their target price on shares of Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a research note on Monday, March 3rd.

Definitive Healthcare Trading Up 3.3 %

Shares of DH opened at $2.84 on Friday. The stock has a fifty day moving average of $2.79 and a two-hundred day moving average of $3.93. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. Definitive Healthcare has a fifty-two week low of $2.15 and a fifty-two week high of $7.47. The company has a market capitalization of $306.61 million, a PE ratio of -0.92, a price-to-earnings-growth ratio of 4.06 and a beta of 1.48.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Thursday, February 27th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.04). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The firm had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. As a group, analysts forecast that Definitive Healthcare will post 0.16 EPS for the current year.

Institutional Investors Weigh In On Definitive Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the business. Nisa Investment Advisors LLC lifted its position in shares of Definitive Healthcare by 3,652.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock valued at $29,000 after buying an additional 6,794 shares during the last quarter. Bayesian Capital Management LP acquired a new position in Definitive Healthcare in the 4th quarter worth approximately $41,000. Ieq Capital LLC acquired a new position in Definitive Healthcare during the fourth quarter valued at $51,000. KLP Kapitalforvaltning AS acquired a new position in Definitive Healthcare in the fourth quarter valued at approximately $54,000. Finally, Two Sigma Securities LLC acquired a new position in shares of Definitive Healthcare in the fourth quarter worth about $56,000. 98.67% of the stock is currently owned by hedge funds and other institutional investors.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.